1. Home
  2. QDEL vs CBLL Comparison

QDEL vs CBLL Comparison

Compare QDEL & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$13.33

Market Cap

989.5M

Sector

Health Care

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$27.30

Market Cap

935.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
QDEL
CBLL
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
989.5M
935.3M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
QDEL
CBLL
Price
$13.33
$27.30
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$14.67
★ $28.57
AVG Volume (30 Days)
★ 2.0M
380.0K
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
45.35
★ 56.93
EPS
N/A
★ N/A
Revenue
★ $2,730,200,000.00
$89,063,000.00
Revenue This Year
N/A
$29.66
Revenue Next Year
$1.85
$27.36
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.09
52 Week Low
$9.92
$10.85
52 Week High
$35.58
$28.11

Technical Indicators

Market Signals
Indicator
QDEL
CBLL
Relative Strength Index (RSI) 53.87 60.89
Support Level $13.04 $22.64
Resistance Level $17.86 N/A
Average True Range (ATR) 1.09 1.51
MACD 0.19 0.24
Stochastic Oscillator 67.80 86.34

Price Performance

Historical Comparison
QDEL
CBLL

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Share on Social Networks: